Keyphrases
Patient-Reported Outcomes Measurement Information System (PROMIS)
100%
Functional Assessment of Cancer Therapy
45%
Health-related Quality of Life
44%
Symptom Score
39%
Content Validity
33%
Breast Cancer Patients
33%
Breast Cancer
32%
Cancer Treatment
31%
Medical Oncologist
29%
United States
22%
Survivors
22%
Patient Preference
21%
Hispanic
21%
Public Health
20%
Biosimilar
19%
Cancer Communication
19%
African American
19%
Treatment Tolerability
19%
Qualitative Development
19%
Supportive Cancer Care
19%
Global Indicators
19%
Hepatocellular Carcinoma
19%
Itch
19%
Paroxysmal Nocturnal Hemoglobinuria
19%
Gynecologic Cancer Survivors
19%
Sleep Disturbance
16%
Intervention Components
16%
Quality of Life
15%
Survivorship
14%
Cancer Experience
14%
In Cancer
14%
Multiphase Optimization Strategy
14%
Black Women
13%
Treatment Side Effects
12%
Breast Cancer Survivors
12%
Behavioral Sleep Intervention
12%
Functional Assessment
12%
Chronic Illness
12%
Structured Interview
12%
Ethnic Minorities
12%
Lymphoma
12%
Risk Perception
12%
Mixed-methods Study
12%
Patient Care
11%
Quality of Life Impact
11%
Cognitive Interview
11%
Kidney Transplant Recipients
11%
Patient-reported Outcomes
11%
Kidney Transplant
11%
Patient-physician
11%
Medicine and Dentistry
Patient-Reported Outcome
72%
Breast Cancer
67%
Quality of Life
60%
Malignant Neoplasm
51%
Cancer Therapy
47%
Functional Assessment
47%
Outcome Assessment
31%
Oncologist
30%
Side Effect
23%
Patient Preference
20%
Awareness
19%
Paroxysmal Nocturnal Hemoglobinuria
19%
Biosimilar
19%
Female Genital Tract Cancer
19%
Diseases
16%
Clinician
16%
Sleep Disorder
13%
Decision Making
12%
Kidney Graft
12%
Ravulizumab
12%
Chronic Disease
12%
Patient Care
11%
Symptomatic Treatment
11%
Eculizumab
11%
Combination Therapy
10%
Public Health
10%
Health Care
10%
Breast Lump
9%
Cancer in Young Adults
9%
Tumor Treating Fields
9%
Gynecological Oncology
9%
Non Small Cell Lung Cancer
9%
Tamoxifen
9%
Infection
9%
Idiopathic Pulmonary Fibrosis
9%
Epileptic Seizure
9%
Rare Disease
9%
Hepatocellular Carcinoma
9%
Systemic Lupus Erythematosus
9%
Shared Decision Making
9%
Rheumatoid Arthritis
9%
Carcinoid Syndrome
9%
Antithrombotic
9%
Neuropathy
9%
Transdermal
9%
Oxaliplatin
9%
B Cell
9%
Intracranial Tumor
9%
Non-Hodgkin Lymphoma
9%
Colorectal Carcinoma
9%
Nursing and Health Professions
Patient-Reported Outcome
67%
Functional Assessment
55%
Cancer Therapy
53%
Breast Cancer
43%
Side Effect
40%
Malignant Neoplasm
33%
Outcome Assessment
29%
Information Systems
29%
Quality of Life
24%
Content Validity
21%
Liver Cell Carcinoma
19%
Nutrition Policy
19%
Combination Therapy
14%
Neuropathy
12%
Kidney Graft
12%
Diseases
12%
Chronic Disease
12%
Patient Care
11%
Patient Preference
10%
Sleep Disorder
10%
Medication Compliance
10%
Rheumatoid Arthritis
9%
Carcinoid Syndrome
9%
Fibrosing Alveolitis
9%
Anticoagulant Agent
9%
Oxaliplatin
9%
Biosimilar Agent
9%
Shared Decision-Making
9%
Public Health Service
9%
Cancer Mortality
9%
Atrial Fibrillation
9%
Female Genital Tract Cancer
9%
Infection
9%
Medical Oncologist
9%
Neoplasm
9%
Anticoagulant Therapy
9%
National Health Organization
9%
Clinical Disease Activity Index
9%
Neurotoxicity
9%
Tamoxifen
9%
Cancer Screening
9%
Colorectal Carcinoma
9%
Ovary Cancer
9%
Nonhodgkin Lymphoma
9%
Inflammatory Arthritis
9%
Cancer Network
9%
Arthralgia
9%
Rare Disease
9%
Patient Safety
9%
Paroxysmal Nocturnal Hemoglobinuria
9%
